The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists-Reference-Cited by-同舟云学术

The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists

Published:2014-01 Issue:1 Volume:24 Page:72-76
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Porter David W.,Bradley Michelle,Brown Zarin,Canova Riccardo,Charlton Steven,Cox Brian,Hunt Peter,Kolarik David,Lewis Sarah,O’Connor Des,Reilly John,Spanka Carsten,Tedaldi Lauren,Watson Simon J.,Wermuth Roland,Press Neil J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes

2. Burden and clinical features of chronic obstructive pulmonary disease (COPD)

3. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

4. Emerging therapies in cystic fibrosis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Asp;Current Medicinal Chemistry;2024-04

2. Therapeutic inhibition of CXCR1/2: where do we stand?;Internal and Emergency Medicine;2023-05-30

3. Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment;Frontiers in Oncology;2023-04-11

4. A protocol for the gram-scale synthesis of polyfluoroaryl sulfides via an S Ar step;STAR Protocols;2023-03

5. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists;Chemical Communications;2022